Literature DB >> 21141729

Histone and DNA modifications in mental retardation.

Shigeki Iwase1, Yang Shi.   

Abstract

Mental retardation (MR), which affects 1-3% of the total population, refers to a pathological condition whereby the affected individuals suffer from cognitive impairment, which is diagnosed by a low intelligence quotient (IQ) (< 70). Over the years, human genetic studies identified a plethora of candidate genes causing MR, but mechanisms by which these candidates regulate cognitive function remain poorly understood. While the functions of MR genes range from cell signaling and gene expression to synaptic plasticity, there is growing evidence supporting a critical role for epigenetic and chromatin regulatory proteins in MR. Excitingly, recent molecular and genetic studies suggest the possibility of improving cognitive functions via modulation of epigenetic regulators, highlighting a potentially new avenue for therapeutic intervention. In this review, we discuss recent studies on epigenetic regulation in MR and explore the concept of epigenetic therapy for MR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21141729     DOI: 10.1007/978-3-7643-8989-5_8

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  6 in total

Review 1.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  Mutations in the intellectual disability gene KDM5C reduce protein stability and demethylase activity.

Authors:  Emily Brookes; Benoit Laurent; Katrin Õunap; Renee Carroll; John B Moeschler; Michael Field; Charles E Schwartz; Jozef Gecz; Yang Shi
Journal:  Hum Mol Genet       Date:  2015-02-09       Impact factor: 6.150

Review 3.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

Review 4.  Histone methylation: a dynamic mark in health, disease and inheritance.

Authors:  Eric L Greer; Yang Shi
Journal:  Nat Rev Genet       Date:  2012-04-03       Impact factor: 53.242

5.  Molecular and cellular issues of KMT2A variants involved in Wiedemann-Steiner syndrome.

Authors:  Nicolas Lebrun; Irina Giurgea; Alice Goldenberg; Anne Dieux; Alexandra Afenjar; Jamal Ghoumid; Bertrand Diebold; Léo Mietton; Audrey Briand-Suleau; Pierre Billuart; Thierry Bienvenu
Journal:  Eur J Hum Genet       Date:  2017-12-04       Impact factor: 4.246

6.  Mutually suppressive roles of KMT2A and KDM5C in behaviour, neuronal structure, and histone H3K4 methylation.

Authors:  Christina N Vallianatos; Brynne Raines; Robert S Porter; Katherine M Bonefas; Michael C Wu; Patricia M Garay; Katie M Collette; Young Ah Seo; Yali Dou; Catherine E Keegan; Natalie C Tronson; Shigeki Iwase
Journal:  Commun Biol       Date:  2020-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.